129 related articles for article (PubMed ID: 38300595)
1. Circulating Tumor DNA Posttreatment Measurements and Clinical Correlates in Retinoblastoma.
Abramson DH; Robbins MA; Gobin YP; Dunkel IJ; Francis JH
JAMA Ophthalmol; 2024 Mar; 142(3):257-261. PubMed ID: 38300595
[TBL] [Abstract][Full Text] [Related]
2.
Francis JH; Gobin YP; Brannon AR; Swartzwelder CE; Berger MF; Mandelker DL; Walsh MF; Dunkel IJ; Abramson DH
Ophthalmol Sci; 2021 Sep; 1(3):100042. PubMed ID: 36247821
[TBL] [Abstract][Full Text] [Related]
3. Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot study.
Abramson DH; Mandelker DL; Brannon AR; Dunkel IJ; Benayed R; Berger MF; Arcila ME; Ladanyi M; Friedman DN; Jayakumaran G; Diosdado MS; Robbins MA; Haggag-Lindgren D; Shukla N; Walsh MF; Kothari P; Tsui DWY; Francis JH
PLoS One; 2023; 18(2):e0271505. PubMed ID: 36735656
[TBL] [Abstract][Full Text] [Related]
4. Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma.
Abramson DH; Mandelker D; Francis JH; Dunkel IJ; Brannon AR; Benayed R; Berger MF; Arcila ME; Ladanyi M; Friedman DN; Jayakumaran G; Diosdado MS; Robbins MA; Haggag-Lindgren D; Shukla N; Walsh M; Kothari P; Tsui DWY
Ophthalmol Sci; 2021 Mar; 1(1):100015. PubMed ID: 36246006
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy in Retinoblastoma: A review.
Ghose N; Kaliki S
Semin Ophthalmol; 2022; 37(7-8):813-819. PubMed ID: 35604935
[TBL] [Abstract][Full Text] [Related]
6. Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience.
Kothari P; Marass F; Yang JL; Stewart CM; Stephens D; Patel J; Hasan M; Jing X; Meng F; Enriquez J; Huberman K; Viale A; Francis JH; Berger MF; Shukla N; Abramson DH; Dunkel IJ; Tsui DWY
Cancer Med; 2020 Sep; 9(17):6093-6101. PubMed ID: 32633890
[TBL] [Abstract][Full Text] [Related]
7. Cell Free DNA (cfDNA) in the Blood of Retinoblastoma Patients The Robert M. Ellsworth Lecture.
Abramson DH
Ophthalmic Genet; 2022 Dec; 43(6):731-735. PubMed ID: 35382685
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis.
Jiménez I; Frouin É; Chicard M; Dehainault C; Le Gall J; Benoist C; Gauthier A; Lapouble E; Houdayer C; Radvanyi F; Bernard V; Brisse HJ; Gauthier-Villars M; Stoppa-Lyonnet D; Baulande S; Cassoux N; Lumbroso L; Matet A; Aerts I; Renault V; Doz F; Golmard L; Delattre O; Schleiermacher G
Eur J Cancer; 2021 Sep; 154():277-287. PubMed ID: 34298378
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
[TBL] [Abstract][Full Text] [Related]
10. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
Tie J; Cohen JD; Wang Y; Christie M; Simons K; Lee M; Wong R; Kosmider S; Ananda S; McKendrick J; Lee B; Cho JH; Faragher I; Jones IT; Ptak J; Schaeffer MJ; Silliman N; Dobbyn L; Li L; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
JAMA Oncol; 2019 Dec; 5(12):1710-1717. PubMed ID: 31621801
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.
Garcia-Murillas I; Chopra N; Comino-Méndez I; Beaney M; Tovey H; Cutts RJ; Swift C; Kriplani D; Afentakis M; Hrebien S; Walsh-Crestani G; Barry P; Johnston SRD; Ring A; Bliss J; Russell S; Evans A; Skene A; Wheatley D; Dowsett M; Smith IE; Turner NC
JAMA Oncol; 2019 Oct; 5(10):1473-1478. PubMed ID: 31369045
[TBL] [Abstract][Full Text] [Related]
12. Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
Radovich M; Jiang G; Hancock BA; Chitambar C; Nanda R; Falkson C; Lynce FC; Gallagher C; Isaacs C; Blaya M; Paplomata E; Walling R; Daily K; Mahtani R; Thompson MA; Graham R; Cooper ME; Pavlick DC; Albacker LA; Gregg J; Solzak JP; Chen YH; Bales CL; Cantor E; Shen F; Storniolo AMV; Badve S; Ballinger TJ; Chang CL; Zhong Y; Savran C; Miller KD; Schneider BP
JAMA Oncol; 2020 Sep; 6(9):1410-1415. PubMed ID: 32644110
[TBL] [Abstract][Full Text] [Related]
13. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.
Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP
JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112
[TBL] [Abstract][Full Text] [Related]
14. Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases.
Wang DS; Yang H; Liu XY; Chen ZG; Wang Y; Fong WP; Hu MT; Zheng YC; Zheng Y; Li BK; Yuan YF; Chen G; Pan ZZ; Song L; Li YH; Xu RH
Theranostics; 2021; 11(14):7018-7028. PubMed ID: 34093868
[No Abstract] [Full Text] [Related]
15. MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer.
Khakoo S; Carter PD; Brown G; Valeri N; Picchia S; Bali MA; Shaikh R; Jones T; Begum R; Rana I; Wotherspoon A; Terlizzo M; von Loga K; Kalaitzaki E; Saffery C; Watkins D; Tait D; Chau I; Starling N; Hubank M; Cunningham D
Clin Cancer Res; 2020 Jan; 26(1):183-192. PubMed ID: 31852830
[TBL] [Abstract][Full Text] [Related]
16. Initial Report: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer.
Eckhoff AM; Kanu E; Fletcher A; Bao M; Aushev VN; Spickard E; Nussbaum DP; Allen PJ
Ann Surg Oncol; 2024 Mar; 31(3):1444-1446. PubMed ID: 38170407
[TBL] [Abstract][Full Text] [Related]
17. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
Tie J; Wang Y; Cohen J; Li L; Hong W; Christie M; Wong HL; Kosmider S; Wong R; Thomson B; Choi J; Fox A; Field K; Burge M; Shannon J; Kotasek D; Tebbutt NC; Karapetis C; Underhill C; Haydon A; Schaeffer J; Ptak J; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
PLoS Med; 2021 May; 18(5):e1003620. PubMed ID: 33939694
[TBL] [Abstract][Full Text] [Related]
19. Circulating Tumor DNA Dynamics as Prognostic Markers in Locally Advanced and Metastatic Esophageal Squamous Cell Carcinoma.
Ng HY; Ko JMY; Lam KO; Kwong DLW; Lo AWI; Wong IYH; Wong CLY; Chan SY; Chan KK; Law TT; Dai W; Fong HCH; Choy FSF; Lo CK; Chen C; Law SYK; Lung ML
JAMA Surg; 2023 Nov; 158(11):1141-1150. PubMed ID: 37728901
[TBL] [Abstract][Full Text] [Related]
20. Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy.
Francis JH; Roosipu N; Levin AM; Brodie SE; Dunkel IJ; Gobin YP; Abramson DH
Neoplasia; 2018 Aug; 20(8):757-763. PubMed ID: 29940303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
